Products
Online Inquiry
IWR-1
Cat. No.:
OB0225WX-1696
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
IWR-1 is a small molecule antagonist of the Wnt pathway that functions by increasing the stability of the axin-mediated destruction complex (EC50 = 0.2 μM).
Synonym:
IWR-1-endo; Endo-IWR 1; 1127442-82-3; 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(quinolin-8-yl)benzamide; rel-4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide; IWR-1 endo; 4-((3aR,4S,7R,7aS)-1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-N-(quinolin-8-yl)benzamide; IWR1-endo; MFCD18086875; IRW1; rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide; 4-[(1R,2S,6R,7S)-3,5-dioxo-4-azatricyclo[5.2.1.0{2,6}]dec-8-en-4-yl]-N-(quinolin-8-yl)benzamide; 4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]-N-quinolin-8-ylbenzamide; Benzamide, 4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-
CAS No.:
1127442-82-3
Compound CID:
44483163
Formula:
C25H19N3O3
Formula Weight:
409.44
Specification
Targets&IC50:
Wnt: 0.2 μM (EC50)
Relative Density:
1.425 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
IWR-1 is applied in developmental biology and regenerative medicine as a tankyrase inhibitor to investigate the biochemical stabilization of the beta-catenin destruction complex.
Library Information
Target:
Wnt/β-Catenin
Receptor:
Wnt
Pathways:
Cytoskeletal signaling; Stem cells
Plate Number:
AOCL-22
Plate Location:
f11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
15 mg/mL; 36.64 mM
Special Max Solubility:
Saline: 4.09 mg/mL; 9.99 mM
ALogP:
3.075
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
3





